ALGN - Align Technology, Inc.
NASDAQ
->
Healthcare
->
Medical Devices
Tempe,
United States
Type: Equity
ALGN price evolution
ALGN
| (in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $937.44 | $1239.01 | $951.96 | $832.38 |
| Short term investments | $35.3 | $44.79 | $55.8 | $51.64 |
| Net receivables | $903.42 | $904.18 | $908.39 | $884.43 |
| Inventory | $296.9 | $296.19 | $312.74 | $311.88 |
| Total current assets | $2446.62 | $2701.8 | $2465.46 | $2331.88 |
| Long term investments | $8.02 | $18.14 | $26.02 | $37.38 |
| Property, plant & equipment | $1408.86 | $1387.35 | $1404.92 | $1380.7 |
| Goodwill & intangible assets | $501.65 | $487.04 | $504.06 | $507.54 |
| Total noncurrent assets | $3637.26 | $3616.75 | $3679.09 | $3569.57 |
| Total investments | $43.33 | $62.93 | $81.83 | $89.02 |
| Total assets | $6083.88 | $6318.55 | $6144.55 | $5901.45 |
| Current liabilities | ||||
| Accounts payable | $113.13 | $99.69 | $110.16 | $130.56 |
| Deferred revenue | $1427.71 | $1408.83 | $1396.75 | $1376.79 |
| Short long term debt | ||||
| Total current liabilities | $2066.61 | $2122.99 | $2107.07 | $2004.6 |
| Long term debt | $96.97 | $98.52 | $104.65 | $99 |
| Total noncurrent liabilities | $386.78 | $393.7 | $399.18 | $416.8 |
| Total debt | $96.97 | $98.52 | $104.65 | $99 |
| Total liabilities | $2453.39 | $2516.68 | $2506.25 | $2421.4 |
| Shareholders' equity | ||||
| Retained earnings | $2447.17 | $2606.75 | $2485.33 | $2373.51 |
| Other shareholder equity | $3630.49 | $3801.87 | $11.34 | $1.83 |
| Total shareholder equity | $3630.49 | $3801.87 | $3638.3 | $3480.05 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $937.44 | $942.05 | $1099.37 | $960.84 |
| Short term investments | $35.3 | $57.53 | $71.97 | |
| Net receivables | $903.42 | $859.68 | $897.2 | $657.7 |
| Inventory | $296.9 | $338.75 | $230.23 | $139.24 |
| Total current assets | $2446.62 | $2424.39 | $2494.07 | $1849.54 |
| Long term investments | $8.02 | $41.98 | $125.32 | |
| Property, plant & equipment | $1408.86 | $1350.73 | $1203.18 | $817.27 |
| Goodwill & intangible assets | $501.65 | $503.27 | $528.26 | $574.89 |
| Total noncurrent assets | $3637.26 | $3523.56 | $3448.03 | $2980.14 |
| Total investments | $43.33 | $99.51 | $197.29 | |
| Total assets | $6083.88 | $5947.95 | $5942.11 | $4829.68 |
| Current liabilities | ||||
| Accounts payable | $113.13 | $127.87 | $163.89 | $142.13 |
| Deferred revenue | $1427.71 | $1343.64 | $1152.87 | $777.89 |
| Short long term debt | ||||
| Total current liabilities | $2066.61 | $1925.89 | $1924.07 | $1325.6 |
| Long term debt | $96.97 | $100.33 | $102.66 | $64.44 |
| Total noncurrent liabilities | $386.78 | $420.7 | $395.32 | $270.22 |
| Total debt | $96.97 | $100.33 | $102.66 | $64.44 |
| Total liabilities | $2453.39 | $2346.59 | $2319.4 | $1595.82 |
| Shareholders' equity | ||||
| Retained earnings | $2447.17 | $2566.69 | $2619.37 | $2215.8 |
| Other shareholder equity | $3630.49 | $3601.36 | $4.33 | $43.5 |
| Total shareholder equity | $3630.49 | $3601.36 | $3622.71 | $3233.86 |
| (in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $956.73 | $960.21 | $1002.17 | $943.15 |
| Cost of revenue | $288.56 | $282.49 | ||
| Gross Profit | $669.52 | $663.08 | $713.61 | $660.65 |
| Operating activities | ||||
| Research & development | $88.48 | $87.45 | ||
| Selling, general & administrative | $453.19 | $439.69 | ||
| Total operating expenses | $484.66 | $496.73 | $541.68 | $527.14 |
| Operating income | $171.93 | $133.52 | ||
| Income from continuing operations | ||||
| EBIT | $171.59 | $134.62 | ||
| Income tax expense | $48.87 | $40.68 | $59.77 | $46.83 |
| Interest expense | $4.98 | $5.52 | ||
| Net income | ||||
| Net income | $124.01 | $121.43 | $111.81 | $87.8 |
| Income (for common shares) | $111.81 | $87.8 | ||
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3862.26 | $3734.64 | $2471.94 | |
| Cost of revenue | $1100.86 | $708.71 | ||
| Gross Profit | $2706.86 | $2633.78 | $1763.23 | |
| Operating activities | ||||
| Research & development | $305.26 | $175.31 | ||
| Selling, general & administrative | $1674.47 | $1200.76 | ||
| Total operating expenses | $2050.21 | $1991.18 | $1376.06 | |
| Operating income | $642.6 | $387.17 | ||
| Income from continuing operations | ||||
| EBIT | $599.06 | $378.95 | ||
| Income tax expense | $196.15 | $237.48 | -$1396.94 | |
| Interest expense | $17.26 | |||
| Net income | ||||
| Net income | $445.05 | $361.57 | $1775.89 | |
| Income (for common shares) | $361.57 | $1775.89 | ||
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $124.01 | $121.43 | $111.81 | $87.8 |
| Operating activities | ||||
| Depreciation | $42.8 | $45.53 | $43.59 | $43.58 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $38.83 | $39.6 | $37.86 | $37.73 |
| Total cash flows from operations | $46.9 | $287.21 | $251.78 | $199.9 |
| Investing activities | ||||
| Capital expenditures | -$33.41 | -$21.64 | -$58.55 | -$64.12 |
| Investments | $19.94 | $17.28 | -$67.01 | $11.28 |
| Total cash flows from investing | -$13.32 | -$4.3 | -$125.48 | -$52.83 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$310 | $12.34 | -$278.1 | |
| Net borrowings | ||||
| Total cash flows from financing | -$350.28 | $11.83 | -$0.93 | -$258.96 |
| Effect of exchange rate | $15.88 | -$7.68 | -$5.74 | $2.22 |
| Change in cash and equivalents | -$300.83 | $287.05 | $119.62 | -$109.67 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $445.05 | $361.57 | $772.02 | $1775.89 |
| Operating activities | ||||
| Depreciation | $175.51 | $156.31 | $135.54 | $116 |
| Business acquisitions & disposals | -$12.3 | -$8 | -$420.79 | |
| Stock-based compensation | $154.03 | $133.37 | $114.34 | $98.43 |
| Total cash flows from operations | $785.78 | $568.73 | $1172.54 | $662.17 |
| Investing activities | ||||
| Capital expenditures | -$177.72 | -$291.9 | -$401.1 | -$154.92 |
| Investments | -$18.5 | $93.1 | -$192.72 | $343.04 |
| Total cash flows from investing | -$195.94 | -$213.32 | -$563.43 | -$231.51 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$575.76 | -$448.89 | -$349.42 | $20.31 |
| Net borrowings | ||||
| Total cash flows from financing | -$598.34 | -$501.69 | -$458.33 | -$30.81 |
| Effect of exchange rate | $4.67 | -$11.51 | -$12.12 | $10.48 |
| Change in cash and equivalents | -$3.84 | -$157.78 | $138.66 | $410.34 |
News
Fundamentals
| Market cap | $23.08B |
|---|---|
| Enterprise value | $22.24B |
| Shares outstanding | 76.59M |
| Revenue | $3.86B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $445.05M |
| Revenue Q/Q | 6.12% |
| Revenue Y/Y | N/A |
| P/E ratio | 51.86 |
|---|---|
| EV/Sales | 5.76 |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 5.98 |
| P/B ratio | InfinityT |
| Book/Share | 0.00 |
| Cash/Share | 12.24 |
| EPS | $5.81 |
|---|---|
| ROA | 7.28% |
| ROE | 12.23% |
| Debt/Equity | 0.68 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.18 |
| Quick ratio | 1.04 |